Terms: = Head and neck cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802
479 results:
1. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract] [Full Text] [Related]
2. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.
Li R; Wang Q; Zhao Y; Zhu Y; Wang X
Mol Biol Rep; 2024 Mar; 51(1):455. PubMed ID: 38536540
[TBL] [Abstract] [Full Text] [Related]
3. Supramolecular nanodrug targeting cdk4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
[TBL] [Abstract] [Full Text] [Related]
4. Artificial intelligence for classification and detection of oral mucosa lesions on photographs: a systematic review and meta-analysis.
Rokhshad R; Mohammad-Rahimi H; Price JB; Shoorgashti R; Abbasiparashkouh Z; Esmaeili M; Sarfaraz B; Rokhshad A; Motamedian SR; Soltani P; Schwendicke F
Clin Oral Investig; 2024 Jan; 28(1):88. PubMed ID: 38217733
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
6. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
7. M1 macrophages induce PD-L1
Wu J; Pang X; Yang X; Zhang M; Chen B; Fan H; Wang H; Yu X; Tang Y; Liang X
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148114
[TBL] [Abstract] [Full Text] [Related]
8. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.
Hsieh MJ; Lin CC; Lo YS; Ho HY; Chuang YC; Chen MK
J Cell Mol Med; 2024 Jan; 28(2):e18071. PubMed ID: 38044583
[TBL] [Abstract] [Full Text] [Related]
9. A Phase I Study of the cdk4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced head and neck Squamous Cell Carcinoma.
Ngamphaiboon N; Pattaranutaporn P; Lukerak S; Siripoon T; Jinawath A; Arsa L; Shantavasinkul PC; Taonam N; Trachu N; Jinawath N; Kositwattanarerk A; Sananmuang T; Jiarpinitnun C
Clin Cancer Res; 2024 Jan; 30(2):294-303. PubMed ID: 37982827
[TBL] [Abstract] [Full Text] [Related]
10. cdk4 phosphorylation status and rational use for combining cdk4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
11. ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma.
Mahieu CI; Mancini AG; Vikram EP; Planells-Palop V; Joseph NM; Tward AD
Mol Cancer Res; 2024 Feb; 22(2):152-168. PubMed ID: 37930255
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
[TBL] [Abstract] [Full Text] [Related]
13. Poor oral health influences head and neck cancer patient survival: an International head and neck cancer Epidemiology Consortium pooled analysis.
Tasoulas J; Farquhar DR; Sheth S; Hackman T; Yarbrough WG; Agala CB; Koric A; Giraldi L; Fabianova E; Lissowska J; Świątkowska B; Vilensky M; Wünsch-Filho V; de Carvalho MB; López RVM; Holcátová I; Serraino D; Polesel J; Canova C; Richiardi L; Zevallos JP; Ness A; Pring M; Thomas SJ; Dudding T; Lee YA; Hashibe M; Boffetta P; Olshan AF; Divaris K; Amelio AL
J Natl Cancer Inst; 2024 Jan; 116(1):105-114. PubMed ID: 37725515
[TBL] [Abstract] [Full Text] [Related]
14. Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic head and neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B; Hong MH; Shin SH; Heo SG; Kim JE; Ahn HK; Lee YG; Park KU; Yun T; Lee KW; Kim SB; Lee SC; Kim MK; Cho SH; Oh SY; Park SG; Hwang S; Nam BH; Kim S; Kim HR; Yun HJ;
J Clin Oncol; 2024 Feb; 42(5):507-517. PubMed ID: 37699162
[TBL] [Abstract] [Full Text] [Related]
15. N6-methyladenosine-induced METTL1 promotes tumor proliferation via cdk4.
Zhang C; Cui Y
Biol Chem; 2024 Mar; 405(3):217-228. PubMed ID: 37694982
[TBL] [Abstract] [Full Text] [Related]
16. Odontogenic Carcinosarcoma: Clinicopathologic and Molecular Features of Three Cases, a Literature Review and Nomenclature Proposal.
Cole G; Chi A; Cook DR; Kubik M; Bilodeau EA; Seethala RR
Head Neck Pathol; 2023 Sep; 17(3):751-767. PubMed ID: 37486533
[TBL] [Abstract] [Full Text] [Related]
17. Investigation of autosegmentation techniques on T2-weighted MRI for off-line dose reconstruction in MR-linac workflow for head and neck cancers.
McDonald BA; Cardenas CE; O'Connell N; Ahmed S; Naser MA; Wahid KA; Xu J; Thill D; Zuhour RJ; Mesko S; Augustyn A; Buszek SM; Grant S; Chapman BV; Bagley AF; He R; Mohamed ASR; Christodouleas J; Brock KK; Fuller CD
Med Phys; 2024 Jan; 51(1):278-291. PubMed ID: 37475466
[TBL] [Abstract] [Full Text] [Related]
18. Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma.
Ngamphaiboon N; Chairoungdua A; Dajsakdipon T; Jiarpinitnun C
Oral Oncol; 2023 Oct; 145():106520. PubMed ID: 37467684
[TBL] [Abstract] [Full Text] [Related]
19. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of long non-coding RNA GASL1 induces apoptosis and G0/G1 cell cycle arrest in human oral cancer cells.
Zhang R; Tao W; Yu L
Acta Biochim Pol; 2023 Jun; 70(2):271-276. PubMed ID: 37307139
[TBL] [Abstract] [Full Text] [Related]
[Next]
